comparemela.com

Latest Breaking News On - கொள்கை ஆரோக்கியம் - Page 7 : comparemela.com

Back surgery made easier | NewsChannel 3-12

KEYT SAN LUIS OBISPO, Calif. - A breakthrough in spinal surgery is now available on the Central Coast through Tenet Health. This is an advancement of decades of surgical procedures, Orthopedic Spine Surgeon, Dr. James Carr said. Back surgery no longer requires a 6 to 10 inch incision and a long hospital stay, according to Carr. He is the first surgeon in San Luis Obispo County to perform an Oblique Lumbar Inter-body Fusion. With this new minimally invasive procedure, people can get back home and on with their lives. If you re able to have a major spine surgery and go home that day or the next day! Carr said, It s definitely the future.

Bon Secours health system co-founds a patient data aggregation startup

Bon Secours health system co-founds a patient data aggregation startup March 5, 2021 1 The Bon Secours Short Pump Emergency Center at 12320 W. Broad St. The health system is one of 14 systems that co-founded Truveta, a startup that will aggregate and sell anonymized patient data. ( Courtesy of Bon Secours) Bon Secours is getting into the tech startup world. The hospital chain and 13 other U.S. health systems have founded Truveta, a startup company based in Seattle that will consolidate the systems’ patient data into an anonymous format and pool it into a single system that will sell the data in the name of improved medical care and research.

Troubled Mesoblast secures crucial cash buffer from surprise US backer

Troubled Mesoblast secures crucial cash buffer from surprise US backer We’re sorry, this service is currently unavailable. Please try again later. Dismiss Normal text size Advertisement Mesoblast has been given a financial lifeline that analysts expect will give it an 18-month cash buffer after the drug company secured a $138 million investment from a surprise US backer. The ASX-listed $1.45 billion stem cell treatments maker unveiled an unexpected new partner on Tuesday, confirming it had sealed a $US110 million ($138 million) deal with a US investor group led by surgery clinics business, SurgCenter Development. Mesoblast had been in a trading halt since Friday, when its half-year report showed it was running at a $US48.9 million half-year loss. Its auditor PwC said a private placement and future partnership payments were key to the company continuing as a going concern.

New treatment that fights COVID-19 has doctors encouraged

New treatment that fights COVID-19 has doctors encouraged SANTA BARBARA COUNTY, Calif. - There s a new treatment for COVID-19 that s showing great promise in keeping people out of the hospital. Monoclonal antibodies were granted emergency use authorization by the FDA in November, and local health providers have been using them for high-risk patients before severe symptoms develop. It s really the only medicine where we have evidence to use before someone gets sick enough to require oxygen, Cottage Hospital Infectious Disease Dr. David Fisk said. Fisk calls monoclonal antibodies an important tool in the fight against COVID-19. They can help the immune system respond more effectively to the virus.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.